205 related articles for article (PubMed ID: 20623938)
1. [New therapies for spastic movement disorders].
Benecke R; Patejdl R
MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
[No Abstract] [Full Text] [Related]
2. Managing spasticity with drugs.
Simon O; Yelnik AP
Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
[TBL] [Abstract][Full Text] [Related]
3. Comparative profile of tizanidine in the management of spasticity.
Lataste X; Emre M; Davis C; Groves L
Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
[TBL] [Abstract][Full Text] [Related]
4. Anti-spasticity medications.
Al-Shahrani AM
Saudi Med J; 2003 Jan; 24(1):19-22. PubMed ID: 12590267
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of spasticity].
Autti-Rämö I
Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
[No Abstract] [Full Text] [Related]
6. Drug treatments for spasticity.
Yelnik AP; Simon O; Bensmail D; Chaleat-Valayer E; Decq P; Dehail P; Quentin V; Marque P; Parratte B; Pellas F; Rousseaux M; Trocello JM; Uzzan M; Dumarcet N;
Ann Phys Rehabil Med; 2009 Dec; 52(10):746-56. PubMed ID: 19892619
[No Abstract] [Full Text] [Related]
7. [Pharmacology of spasticity. Does therapy remain in deep sleep?].
Noth J
Nervenarzt; 2000 Dec; 71(12):927-8. PubMed ID: 11139987
[No Abstract] [Full Text] [Related]
8. An approach to switching patients from baclofen to tizanidine.
Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic interventions for reducing spasticity in cerebral palsy.
Patel DR; Soyode O
Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
[TBL] [Abstract][Full Text] [Related]
10. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
Lipták J
Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
[No Abstract] [Full Text] [Related]
11. The pharmacological management of spasticity.
Saulino M; Jacobs BW
J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
[TBL] [Abstract][Full Text] [Related]
12. Drugs used to treat spasticity.
Kita M; Goodkin DE
Drugs; 2000 Mar; 59(3):487-95. PubMed ID: 10776831
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
14. [Comparative effciency of bakloferon and tolperizon central muscle relaxants in complex therapy of back pain].
Vorob'eva OV; Kozlova IM
Voen Med Zh; 2006 Sep; 327(9):52-5. PubMed ID: 17180860
[No Abstract] [Full Text] [Related]
15. Pharmacologic management of spasticity in cerebral palsy.
Mooney JF; Koman LA; Smith BP
J Pediatr Orthop; 2003; 23(5):679-86. PubMed ID: 12960637
[No Abstract] [Full Text] [Related]
16. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
17. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
Groves L; Shellenberger MK; Davis CS
Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies.
Knutsson E
Adv Neurol; 1983; 39():1013-34. PubMed ID: 6229155
[No Abstract] [Full Text] [Related]
19. Treatment alternatives for spinal cord injury related spasticity.
Kirshblum S
J Spinal Cord Med; 1999; 22(3):199-217. PubMed ID: 10685385
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity.
Delwaide PJ
Ann Neurol; 1985 Jan; 17(1):90-5. PubMed ID: 3985591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
